|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From Departments of Nutrition (MT, FBH) and Epidemiology (EC), Harvard School of Public Health, the Channing Laboratory, Boston, and the Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (JEM).
Background: Nutritional therapy is a cornerstone of diabetes management, but no epidemiologic studies have investigated the relation between specific dietary fatty acids and cholesterol and cardiovascular disease (CVD) risk among diabetic patients.
Objective: This study assessed the relation between specific dietary fatty acids and cholesterol and CVD risk among women with type 2 diabetes.
Design: Among 5672 women with type 2 diabetes from the Nurses' Health Study, diet was assessed prospectively and updated periodically. Relative risks of CVD were estimated from Cox proportional hazards analysis after adjustment for potential confounders.
Results: Between 1980 and 1998, we identified 619 new cases of CVD (nonfatal myocardial infarction, fatal coronary heart disease, and stroke). The relative risk (RR) of CVD for an increase of 200 mg cholesterol/1000 kcal was 1.37 (95% CI: 1.12, 1.68; P = 0.003). Each 5% of energy intake from saturated fat, as compared with equivalent energy from carbohydrates, was associated with a 29% greater risk of CVD (RR: 1.29; 95% CI: 1.02, 1.63; P = 0.04). The ratio of polyunsaturated to saturated fat (P:S) was inversely associated with the risk of fatal CVD. We estimated that replacement of 5% of energy from saturated fat with equivalent energy from carbohydrates or monounsaturated fat was associated with a 22% or 37% lower risk of CVD, respectively.
Conclusions: A higher intake of cholesterol and saturated fat and a low P:S were related to increased CVD risk among women with type 2 diabetes. Among diabetic persons, replacement of saturated fat with monounsaturated fat may be more effective in lowering CVD risk than is replacement with carbohydrates.
Key Words: Dietary fat dietary cholesterol diabetes mellitus cardiovascular diseases epidemiology
Related articles in AJCN:
This article has been cited by other articles:
![]() |
A. M Zivkovic, J B. German, and A. J Sanyal Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Kabagambe, A. Baylin, and H. Campos Nonfatal Acute Myocardial Infarction in Costa Rica: Modifiable Risk Factors, Population-Attributable Risks, and Adherence to Dietary Guidelines Circulation, March 6, 2007; 115(9): 1075 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sirikulchayanonta, P. Pavadhgul, R. Chongsuwat, and S. Srisorrachata A preliminary study of hyperlipidemia in Bangkok school children Asia Pac J Public Health, September 1, 2006; 18(3): 15 - 19. [PDF] |
||||
![]() |
F. B Hu Protein, body weight, and cardiovascular health Am. J. Clinical Nutrition, July 1, 2005; 82(1): 242S - 247S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Nestel, K. Baghurst, D. M Colquhoun, R J. Simes, K. Mehalski, H. D White, A. M Tonkin, A. Kirby, C. Pollicino, and for the Long-Term Intervention with Pravastatin in Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1322 - 1329. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |